CBFCX | CIRAX | CBFCX / CIRAX | |
Total Expense Ratio | 1.59 | 0.62 | 256% |
Annual Report Gross Expense Ratio | 1.59 | 0.62 | 256% |
Fund Existence | 15 years | 24 years | - |
Gain YTD | 11.706 | 15.337 | 76% |
Front Load | N/A | 4% | - |
Min. Initial Investment | 250 | 250 | 100% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 29B | 118B | 25% |
Annual Yield % from dividends | 1.29 | 2.90 | 44% |
Returns for 1 year | 6.12 | 11.89 | 51% |
Returns for 3 years | 32.54 | 40.44 | 80% |
Returns for 5 years | 22.42 | 55.33 | 41% |
Returns for 10 years | 54.63 | 94.63 | 58% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
GNOM | 37.99 | 0.91 | +2.44% |
Global X Genomics & Biotechnology ETF | |||
MQY | 11.19 | 0.15 | +1.36% |
Blackrock Muni Yield Quality Fund | |||
AVSD | 70.10 | 0.41 | +0.59% |
Avantis Responsible International Eq ETF | |||
VYM | 139.55 | 0.26 | +0.19% |
Vanguard High Dividend Yield ETF | |||
LGCF | 33.00 | N/A | N/A |
Themes US Cash Flow Champions ETF |